QBTS analyst scorecard
33 rating actions on QBTS in the last 12 months. Of 38 price targets that resolved, 26 were reached while they stood, 12 were replaced by the same firm first, and 0 fell short at their deadline. Ratings: 100% Buy-type, 0% Hold-type, 0% Sell-type. Consensus target $35, 202% above the last close.
Checked through 2026-10-29 · last close $11.45 (2026-10-29). Rebuilt every morning.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Mizuho | Outperform | 2026-06-15 | $35 | 1 | 2 | 3 | — |
| Rosenblatt | Buy | 2026-08-07 | $43 | 1 | 2 | 3 | 0 of 1 |
| Needham | Buy | 2026-06-02 | $40 | 4 | 2 | 6 | 1 of 1 |
| Benchmark | Buy | 2026-07-27 | $30 | 7 | 2 | 9 | 1 of 1 |
| Wedbush | Outperform | 2025-12-17 | $35 | — | — | 0 | — |
| Jefferies | Buy | 2025-12-16 | $45 | — | — | 0 | — |
| Canaccord Genuity | Buy | 2026-05-13 | $41 | — | — | 0 | 0 of 1 |
| Cantor Fitzgerald | Overweight | 2026-05-13 | $40 | 1 | 0 | 1 | 0 of 1 |
| Evercore ISI Group | Outperform | 2026-02-27 | $42 | 0 | 1 | 1 | — |
| Roth Capital | Buy | 2026-06-02 | $40 | 2 | 0 | 2 | 0 of 1 |
| B. Riley Securities | Buy | 2026-06-02 | $40 | 5 | 3 | 8 | 1 of 1 |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor QBTS carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-08-07 | Rosenblatt | Buy | maintained | $20.76 | $43 | running to 2027-08-07 | +0.6% |
| 2026-07-28 | Rosenblatt | Buy | maintained | $17.64 | $43 | running to 2027-07-28 | -22.5% |
| 2026-07-27 | Benchmark | Buy | initiated | $19.51 | $30 | running to 2027-07-27 | -14.3% |
| 2026-07-27 | Benchmark | Buy | initiated | $19.51 | $30 | running to 2027-07-27 | -14.3% |
| 2026-06-15 | Mizuho | Outperform | maintained | $26.26 | $35 | running to 2027-06-15 | +29.0% |
| 2026-06-11 | Rosenblatt | Buy | maintained | $23.82 | $43 | running to 2027-06-11 | +6.6% |
| 2026-06-02 | B. Riley Securities | Buy | maintained | $29.91 | $40 | running to 2027-06-02 | +46.0% |
| 2026-06-02 | Roth Capital | Buy | maintained | $29.91 | $40 | running to 2027-06-02 | +46.0% |
| 2026-06-02 | Rosenblatt | Buy | maintained | $29.91 | $43 | running to 2027-06-02 | +46.0% |
| 2026-06-02 | Needham | Buy | reiterated | $29.91 | $40 | running to 2027-06-02 | +46.0% |
| 2026-05-13 | Canaccord Genuity | Buy | maintained | $21.44 | $41 | running to 2027-05-13 | +46.4% |
| 2026-05-13 | Rosenblatt | Buy | maintained | $21.44 | $43 | running to 2027-05-13 | +46.4% |
| 2026-05-13 | Cantor Fitzgerald | Overweight | reiterated | $21.44 | $40 | running to 2027-05-13 | +46.4% |
| 2026-05-13 | Mizuho | Outperform | maintained | $21.44 | $29 | reached 2026-05-22 | +46.4% |
| 2026-05-13 | Needham | Buy | reiterated | $21.44 | $40 | running to 2027-05-13 | +46.4% |
| 2026-02-27 | Mizuho | Outperform | maintained | $18.78 | $40 | replaced 2026-05-13, new $29 | -24.8% |
| 2026-02-27 | Evercore ISI Group | Outperform | maintained | $18.78 | $42 | running to 2027-02-27 | -24.8% |
| 2026-02-27 | Roth Capital | Buy | maintained | $18.78 | $30 | reached 2026-05-29 | -24.8% |
| 2026-02-26 | Needham | Buy | maintained | $20.14 | $40 | running to 2027-02-26 | -18.4% |
| 2026-01-29 | Needham | Buy | reiterated | $23.22 | $48 | replaced 2026-02-26, new $40 | -11.5% |
| 2026-01-28 | Rosenblatt | Buy | maintained | $24.97 | $43 | running to 2027-01-28 | -4.5% |
| 2026-01-23 | Benchmark | Buy | reiterated | $25.63 | $35 | replaced 2026-07-27, new $30 | -6.9% |
| 2026-01-22 | Needham | Buy | reiterated | $27.43 | $48 | replaced 2026-02-26, new $40 | -5.8% |
| 2026-01-08 | Rosenblatt | Buy | maintained | $29.28 | $43 | running to 2027-01-08 | +3.4% |
| 2026-01-07 | Rosenblatt | Buy | maintained | $30.20 | $40 | replaced 2026-01-08, new $43 | +6.2% |
| 2025-12-17 | Wedbush | Outperform | initiated | $23.80 | $35 | running to 2026-12-17 | +4.2% |
| 2025-12-16 | Jefferies | Buy | initiated | $25.52 | $45 | running to 2026-12-16 | +8.1% |
| 2025-12-11 | Mizuho | Outperform | initiated | $27.98 | $46 | replaced 2026-02-27, new $40 | -3.5% |
| 2025-12-03 | Evercore ISI Group | Outperform | initiated | $25.08 | $44 | replaced 2026-02-27, new $42 | -24.2% |
| 2025-11-10 | Benchmark | Buy | maintained | $29.37 | $35 | replaced 2026-07-27, new $30 | — |
| 2025-11-07 | Canaccord Genuity | Buy | maintained | $29.50 | $41 | running to 2026-11-07 | — |
| 2025-11-07 | Cantor Fitzgerald | Overweight | maintained | $29.50 | $40 | running to 2026-11-07 | — |
| 2025-11-07 | Rosenblatt | Buy | maintained | $29.50 | $40 | replaced 2026-01-08, new $43 | — |
Also in Quantum
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.